Skip to content

Clinical Performance of Restorative Materials in Primary Teeth

Clinical Performance of Restorative Materials in Class II Cavities of Primary Molar Teeth

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03037814
Enrollment
100
Registered
2017-01-31
Start date
2021-09-28
Completion date
2027-03-25
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries; Dentin, Dental Caries

Keywords

restorative materials, primary teeth, children

Brief summary

The purpose of this study is to evaluate and compare the clinical performance of dental restorative materials in Class II cavities of primary molar teeth

Detailed description

Restorations will be placed on four primary molar teeth with proximal caries, in a split mouth design. 100 patients will be included in the study. The teeth will be randomized into four groups according to the restorative materials. Group 1: Adhesive agent+ Compomer (Dyract AP, Dentsply DeTrey, Konstanz,Germany) Group 2: Primer + Resin modified glass ionomer (Vitremer, 3M ESPE, U.S.) Group 3: Adhesive agent + Giomer (Beautifil II, (Shofu Dental, Tokyo, Japan) Group 4: Amalgam (Permite amalgam, SDI Limited, Bayswater, Australia) The restorations will be evaluated at baseline, 3., 6., 12. months for the first year, and at every 6 months for 5 years. The modified US Public Health Service criteria (secondary caries, marginal integrity, marginal discoloration and retention) will be used for clinical evaluation of restorations. The data will be analysed statistically using Wilcoxon test, chi square test and the Kaplan-Meier survival method will be used to estimate survival percentages.

Interventions

DEVICECompomer

Aesthetic resin dental materials that are used to replace structure loss, commonly for dental caries of primary tooth. Compomers designed to combine the aesthetics of traditional composite resins with the fluoride release and adhesion of glass-ionomer cements.

DEVICERMGIC

Dental restorative materials that are a combination of the desirable properties of glass-ionomer (fluoride release and chemical adhesion) with high strength and low solubility of resins.

DEVICEGiomer

Giomers are dental materials that are hybrid of compomers and glass ionomers, and are used to restore dental caries.

DEVICEAmalgam

Amalgam is a silver-colored dental restorative material that can be used to restore both primary and permanent posterior teeth which have dental caries.

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
4 Years to 7 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients and parent of the patients who accept to participate and sign the informed consent * Patients who have at least four first and/or second primary molars with proximal caries that require class II restorations * Teeth that have healthy lamina dura and periodontal ligament * Teeth that have caries lesions extending no more than the outher half of dentin radiographically

Exclusion criteria

* Patients and parent of the patients who don't accept to participate and sign the informed consent * Teeth that are previously restored * Patients who are uncooperative * Teeth that doesn't have proximal or occlusal contacts with adjacent healthy teeth * Patients who have bruxism, skeletal or dental malocclusion * Teeth that have developmental defects or anomalies

Design outcomes

Primary

MeasureTime frameDescription
Clinical evaluation of restorative materials in class II cavities on primary molar teeth according to the modified USPHS criteria5 yearsLong-term clinical success of different restorative materials in class II cavities on primary molar teeth

Countries

Turkey (Türkiye)

Contacts

Primary ContactZafer C Cehreli, DDS, PhD
zcehreli@gmail.com00905353197969
Backup ContactBeste Ozgur, DDS, PhD
besteisbitiren@yahoo.com005072657769

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026